Max An

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Locally Advanced

Mesenchymal Stem Cells

Ejection Fraction

Disease Activity

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)
Yamini K Kathari, Max An, Christine Dougherty, Ashkan Emadi
Long-Term Follow up of Blinatumomab in Older Patients with B-Cell Acute Lymphoblastic Leukemia. Pharmaceuticals (Basel, Switzerland) 17 (3) (2024)